Variations in blood ghrelin levels in prostate cancer patients submitted to hormone suppressive treatment

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1345-1348

  Bertaccini, Alessandro ^a   Pernetti, Remigio ^a   Marchiori, Debora ^a   Pagotto, Umberto ^a   Palladoro, Federica ^a   Palmieri, Fabiano ^a   Giovanni, Vitullo ^a   Guidi, Mascia ^a   Martorana, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bicalutamide; Ghrelin; Leuprorelin; Prostate cancer

Indexed keywords

ANTIBODY; BICALUTAMIDE; GHRELIN; INSULIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; HISTOLOGY; HORMONAL THERAPY; HUMAN; MALE; MONITORING; PARAMETER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIOIMMUNOASSAY; RADIOIMMUNOLOGY; TREATMENT RESPONSE;

ACYLATION; ADENOCARCINOMA; ADULT; AGED; GHRELIN; HUMANS; INSULIN; LEUPROLIDE; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 64949179196     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yeh AH, Jeffery PL, Duncan RP, Herington AC and Chopin LK: Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates miitogen-activated protein kinase in prostate cancer. Clinical Cancer Res 11: 8295- 8303,2005.
2. Leontiou CA, Franchi G and Korbonits M: Ghrelin in neuroendocrine organs and tumours. Pituitary 10(3): 213-225, 2007.
3. Gambineri A, Pelusi C and Pasquali R: Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome. J Endocrinol Invest 26: 493-498, 2003.
4. Gambineri A, Pagotto U, De Lasio R, Meriggiola MC, Costantino A, Patton L, Pelusi C, Pelusi G and Pasquali R: Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normalweight men. J Endocrinol Invest 28(3): 241-246, 2005.
5. Broglio F, Gottero C, Benso A, Prodam F, Destefanis S, Gauna C, Maccario M, Deghenghi R, van der Lely AJ and Ghigo E: Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab 88: 4268-4272, 2003.
6. Lee HM, Wang G, Englander EW, Kojima M and Greeley GH Jr: Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143: 185- 190, 2002.
7. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschöp M and Pasquali R: Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 87: 5625-5629, 2002.
8. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E and Boyadjian R: Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87: 3997-4000, 2002.
9. Cassoni P, Ghé C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M and Muccioli G: Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150: 173-184, 2004.
10. Rindi G, Torsello A, Locatelli V and Solcia E: Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med 229: 1007-1016, 2004.